Earnings Feed
Start Free
Home/Filings/3/A/0001683168-20-000086
3/A//SEC Filing

E&Investment, Inc. 3/A

Accession 0001683168-20-000086

CIK 0001638287other
View on SEC.govCompany Profile

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 6:11 PM ET

Size

10.6 KB

Accession

0001683168-20-000086

Insider Transaction Report

Form 3/AAmended
Period: 2019-12-30
NeuroBo Pharmaceuticals, Inc.NRBO
E&Investment, Inc.
10% Owner
Holdings

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund No. 7)
    1,864,799

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund No. 6)
    1,121,190

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund II)
    4,335,800
E&Healthcare Investment Fund II
10% Owner
Holdings

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund No. 6)
    1,121,190

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund No. 7)
    1,864,799

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund II)
    4,335,800
E&Healthcare Investment Fund No.7
10% Owner
Holdings

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund II)
    4,335,800

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund No. 7)
    1,864,799

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund No. 6)
    1,121,190
Footnotes (4)
  • [F1]These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund II.
  • [F2]These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund No. 6
  • [F3]These shares are owned directly by The E&Healthcare Investment Fund No.7, a 10% owner of the Issuer, and indirectly by E&Investment, Inc., as sole general partner of The E&Healthcare Investment Fund No.7.
  • [F4]E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

Documents

1 file

Issuer

NeuroBo Pharmaceuticals, Inc.

CIK 0001638287

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001796144

Filing Metadata

Form type
3/A
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 6:11 PM ET
Size
10.6 KB
View on SEC.gov